ATTEMPTED PROPHYLAXIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN CHIMPANZEES WITH A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR

被引：4
|
作者：
SCHLEIF, WA
MURTHY, KK
SARDANA, VV
SCHNEIDER, CL
BYRNES, VW
COBB, KE
ROTH, E
WOLFGANG, JA
HOFFMAN, JM
SMITH, AM
GELOTTE, KM
EMINI, EA
机构：
[1] MERCK SHARP & DOHME LTD,W POINT,PA 19486
[2] SW FDN BIOMED RES,SAN ANTONIO,TX 78284
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 1994年 / 10卷 / 01期
关键词：
D O I：
10.1089/aid.1994.10.107
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：107 / 110
页数：4
相关论文
共 50 条
  • [41] KINETICS OF DIFFERENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE TRANSCRIPTASES RESISTANT TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS
    DEBYSER, Z
    DEVREESE, K
    KNOPSGERRITS, PP
    BAEKELANDT, V
    BHIKHABHAI, R
    STRANDBERG, B
    PAUWELS, R
    ANNE, J
    DESMYTER, J
    DE CLERCQ, E
    MOLECULAR PHARMACOLOGY, 1993, 43 (04) : 521 - 526
  • [42] SENSITIVITY RESISTANCE PROFILE OF A SIMIAN IMMUNODEFICIENCY VIRUS CONTAINING THE REVERSE-TRANSCRIPTASE GENE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TOWARD THE HIV-1-SPECIFIC NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS
    BALZARINI, J
    WEEGER, M
    CAMARASA, MJ
    DECLERCQ, E
    UBERLA, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 211 (03) : 850 - 856
  • [43] VIRAL RESISTANCE TO THE THIAZOLO-ISO-INDOLINONES, A NEW CLASS OF NONNUCLEOSIDE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    MAASS, G
    IMMENDOERFER, U
    KOENIG, B
    LESER, U
    MUELLER, B
    GOODY, R
    PFAFF, E
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (12) : 2612 - 2617
  • [44] THE EFFECTS OF CYSTEINE MUTATIONS ON THE CATALYTIC ACTIVITIES OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    LOYA, S
    TAL, R
    HUGHES, SH
    HIZI, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (20) : 13879 - 13883
  • [45] INHIBITION OF HEAT INACTIVATION OF REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY SEROPOSITIVE SERA
    NAGUMO, T
    TAKEUCHI, Y
    HOSHINO, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (06): : 594 - 600
  • [46] ANALYSIS OF MUTATIONS AT POSITION-184 IN REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    BOYER, PL
    HUGHES, SH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) : 1624 - 1628
  • [47] HIGH-AFFINITY SSDNA INHIBITORS OF THE REVERSE-TRANSCRIPTASE OF TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS
    SCHNEIDER, DJ
    FEIGON, J
    HOSTOMSKY, Z
    GOLD, L
    BIOCHEMISTRY, 1995, 34 (29) : 9599 - 9610
  • [48] THE BINDING OF A NOVEL BISHETEROARYLPIPERAZINE MEDIATES INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    DUEWEKE, TJ
    KEZDY, FJ
    WASZAK, GA
    DEIBEL, MR
    TARPLEY, WG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (01) : 27 - 30
  • [49] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE BY 3'-BLOCKED OLIGONUCLEOTIDE PRIMERS
    AUSTERMANN, S
    KRUHOFFER, M
    GROSSE, F
    BIOCHEMICAL PHARMACOLOGY, 1992, 43 (12) : 2581 - 2589
  • [50] MUTATIONAL ANALYSIS OF RESIDUE-190 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    KLEIM, JP
    BENDER, R
    KIRSCH, R
    MEICHSNER, C
    PAESSENS, A
    RIESS, G
    VIROLOGY, 1994, 200 (02) : 696 - 701
12345